Last Update 20 Mar 26

Fair value Decreased 13%

PATH: Agentic AI Automation And Healthcare Solutions Will Support Future Upside

UiPath's updated analyst fair value estimate has shifted from $15.93 to $13.81 as analysts reset price targets across the $12 to $18 range, weighing solid Q4 execution, AI driven automation traction and improving margins against valuation compression, flat to stabilizing net new ARR, and the need for clearer proof of sustained AI monetization.

Analyst Commentary

Recent research points to a split view on UiPath, with most firms reducing price targets but highlighting both encouraging execution in Q4 and unresolved questions around future growth and valuation.

Bullish Takeaways

Bullish analysts point to a "solid" or "strong" Q4, with results at or above guidance and beats on annualized recurring revenue, as evidence that execution is holding up despite sector pressure.
Several firms highlight traction in AI driven automation, including agentic automation, orchestration via Maestro, and stronger adoption of AI solutions among large customers, which they see as supportive of UiPath's longer term growth opportunity.
Improving margins, free cash flow growth potential, and material margin expansion in Q4 are viewed as supportive of the equity story, especially as software valuations compress.
Some bullish analysts see potential in the vertical go to market approach and the WorkFusion acquisition, which they believe can support organic net new ARR and sector specific automation use cases over time.

Bearish Takeaways

Bearish analysts consistently cut price targets into the US$12 to US$18 band, often citing multiple compression across software and peer valuation resets rather than a breakdown in UiPath's fundamentals.
Several firms flag flat or only stabilizing net new ARR on a constant currency basis and guidance that implies generally flat net new ARR, which they see as limiting the near term growth profile despite Q4 strength.
There is caution that a portion of recent performance reflects FX tailwinds and inorganic ARR from WorkFusion, while guidance points to only limited operating margin expansion from here.
More cautious analysts want clearer proof of sustained AI monetization and revenue growth acceleration, indicating that AI "tailwinds" alone are not yet enough to justify higher valuation multiples.

What's in the News

UiPath announced new security automation built with Microsoft that connects its automation platform with Microsoft Defender for Cloud, Microsoft Sentinel, and Microsoft Security Copilot to automate threat detection, enrichment, and response workflows, with availability through the UiPath Solutions Marketplace (Product related announcement).
UiPath expanded its alliance with Deloitte through the launch of Deloitte’s Agentic ERP offering, which uses UiPath Agent Builder and UiPath Maestro to orchestrate AI agents, robots, systems, and people across core ERP workflows and is embedded into Deloitte’s AI native Agentic ERP architecture with governance supported by the UiPath AI Trust Layer (Client announcement).
UiPath announced new agentic AI solutions for healthcare providers and payers focused on medical records summarization, claim denial prevention and resolution, and prior authorization, delivered in partnership with Genzeon for prior authorization and aimed at revenue cycle management use cases (Product related announcement).
The Board of Directors authorized a new share repurchase program for up to US$500 million with no stated expiration, following prior buyback activity under the program announced on September 6, 2023 (Buyback transaction announcements).
UiPath issued earnings guidance for fiscal 2027, with expected revenue of US$395 million to US$400 million for the first quarter and US$1.754 billion to US$1.759 billion for the full year (Corporate guidance).

Valuation Changes

Fair Value: The updated analyst fair value estimate moved from $15.93 to $13.81, a reduction of about 13% that tightens the implied upside versus current price targets.
Discount Rate: The discount rate shifted slightly from 8.54% to 8.50%, a very small adjustment that has only a modest effect on valuation calculations.
Revenue Growth: The modeled revenue growth rate moved from 8.96% to 8.42%, a moderate pullback that tempers long term growth expectations in the valuation framework.
Net Profit Margin: The projected profit margin increased from 2.94% to 7.17%. This represents a sizeable step up that assumes a more efficient earnings profile over time.
Future P/E: The implied future P/E multiple moved from 168.1x to 64.5x. This is a large reset that lowers the valuation premium embedded in the updated fair value estimate.

37 views

Key Takeaways

Strategic partnerships and innovation in automation aim to boost growth through deeper customer relationships and expanded market opportunities.
Go-to-market restructuring and focus on AI-driven cloud products seek to enhance efficiency, customer engagement, and revenue growth.
Geopolitical and macroeconomic challenges are impacting UiPath's revenue growth, with FX headwinds and SaaS transition affecting financial targets and margins.

Catalysts

About UiPath

Provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.What are the underlying business or industry changes driving this perspective?

UiPath's focus on accelerating innovation across the agentic automation road map is expected to grow deeper customer relationships and strategic partnerships, likely driving future revenue growth.
Increased adoption of UiPath's platform among existing customers, supported by strategic changes in the go-to-market structure, is aimed at enhancing customer engagement and boosting ARR growth.
The completion of go-to-market restructuring is anticipated to improve alignment and operational efficiency, which could lead to better net margins over time.
New product launches such as Agent Builder and Agentic Orchestration, along with strategic partnerships like with Microsoft and Deloitte, are positioned to expand market opportunities, potentially increasing earnings through higher-value deals.
UiPath's commitment to cloud offerings, with over $975 million in cloud ARR, positions the company to capitalize on AI-driven products and services, which could contribute to revenue growth and improved gross margins.

UiPath Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming UiPath's revenue will grow by 8.4% annually over the next 3 years.
Analysts assume that profit margins will shrink from 17.5% today to 7.2% in 3 years time.
Analysts expect earnings to reach $147.2 million (and earnings per share of $0.62) by about March 2029, down from $282.3 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $210.9 million in earnings, and the most bearish expecting $23.7 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 64.5x on those 2029 earnings, up from 23.2x today. This future PE is greater than the current PE for the US Software industry at 29.0x.
Analysts expect the number of shares outstanding to grow by 0.17% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.5%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

The ongoing geopolitical climate and government transitions have caused delays in deal closures, impacting UiPath's ARR expectations and potentially affecting short-term revenue growth.
Increased macroeconomic volatility has introduced uncertainty around customer budgets, leading to a more cautious financial guidance for fiscal 2026, which could impact future earnings and revenue predictability.
Currency fluctuations (FX headwinds) have negatively affected revenue and ARR figures, creating additional challenges in meeting financial targets and impacting net margins.
The move towards a SaaS model has been identified as a 2% revenue growth headwind for the full year, implying potential pressures on net margins during the transition period.
While there is strong innovation in agentic products, these advancements may not significantly contribute to fiscal 2026 revenue, suggesting potential risks to short-term revenue projections despite long-term growth potential.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $13.8 for UiPath based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $17.0, and the most bearish reporting a price target of just $12.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $2.1 billion, earnings will come to $147.2 million, and it would be trading on a PE ratio of 64.5x, assuming you use a discount rate of 8.5%.
Given the current share price of $12.24, the analyst price target of $13.8 is 11.3% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on UiPath?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Expanding Automation Partnerships And AI-Powered Agents Will Drive Business Momentum